Healthcare provider profile · identity verified

Robert Dean Mcelhaney, MD

Family Practice · CHEHALIS, WA · NPI 1730162124

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	716	210
Levothyroxine Sodium	Levothyroxine Sodium	499	132
Losartan Potassium	Losartan Potassium	387	115
Lisinopril	Lisinopril	348	101
Amlodipine Besylate	Amlodipine Besylate	323	95
Omeprazole	Omeprazole	282	90
Rosuvastatin Calcium	Rosuvastatin Calcium	277	77
Gabapentin	Gabapentin	272	79
Metoprolol Succinate	Metoprolol Succinate	247	74
Tamsulosin Hcl	Tamsulosin Hcl	228	70
Furosemide	Furosemide	214	65
Metformin Hcl Er	Metformin Hcl	194	63
Potassium Chloride	Potassium Chloride	186	51
Duloxetine Hcl	Duloxetine Hcl	165	47
Trazodone Hcl	Trazodone Hcl	157	43
Finasteride	Finasteride	142	44
Metoprolol Tartrate	Metoprolol Tartrate	139	43
Carvedilol	Carvedilol	135	40
Eliquis	Apixaban	135	33
Simvastatin	Simvastatin	131	42
Pantoprazole Sodium	Pantoprazole Sodium	130	40
Hydrochlorothiazide	Hydrochlorothiazide	125	38
Metformin Hcl	Metformin Hcl	121	37
Allopurinol	Allopurinol	120	37
Xarelto	Rivaroxaban	114	40
Ozempic	Semaglutide	112	19
Jardiance	Empagliflozin	108	21
Albuterol Sulfate Hfa	Albuterol Sulfate	107	38
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	103	37
Diclofenac Sodium	Diclofenac Sodium	101	42
Escitalopram Oxalate	Escitalopram Oxalate	99	23
Sertraline Hcl	Sertraline Hcl	98	29
Atenolol	Atenolol	94	25
Glimepiride	Glimepiride	92	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	90	31
Farxiga	Dapagliflozin Propanediol	89	32
Azelastine Hcl	Azelastine Hcl	84	45
Spironolactone	Spironolactone	84	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	82	20
Fluoxetine Hcl	Fluoxetine Hcl	80	21
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	80	24
Memantine Hcl	Memantine Hcl	79	24
Mirtazapine	Mirtazapine	78	22
Clopidogrel	Clopidogrel Bisulfate	69	23
Ezetimibe	Ezetimibe	69	21
Bupropion Xl	Bupropion Hcl	67	23
Celecoxib	Celecoxib	65	17
Tramadol Hcl	Tramadol Hcl	63	26
Prednisone	Prednisone	62	15
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	61	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	59	11
Pregabalin	Pregabalin	55	13
Ropinirole Hcl	Ropinirole Hcl	52	14
Mounjaro	Tirzepatide	44	suppressed
Famotidine	Famotidine	43	13
Oxycodone Hcl	Oxycodone Hcl	43	suppressed
Paroxetine Hcl	Paroxetine Hcl	43	13
Citalopram Hbr	Citalopram Hydrobromide	42	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	42	12
Amitriptyline Hcl	Amitriptyline Hcl	41	14
Hydralazine Hcl	Hydralazine Hcl	40	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	40	12
Alendronate Sodium	Alendronate Sodium	39	13
Aripiprazole	Aripiprazole	39	suppressed
Digoxin	Digoxin	38	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	37	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	12
Quetiapine Fumarate	Quetiapine Fumarate	37	suppressed
Ketoconazole	Ketoconazole	36	suppressed
Fenofibrate	Fenofibrate	35	11
Pioglitazone Hcl	Pioglitazone Hcl	35	15
Pravastatin Sodium	Pravastatin Sodium	34	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	34	25
Acyclovir	Acyclovir	32	suppressed
Enalapril Maleate	Enalapril Maleate	32	suppressed
Estradiol	Estradiol	32	11
Solifenacin Succinate	Solifenacin Succinate	32	suppressed
Buspirone Hcl	Buspirone Hcl	31	suppressed
Fluticasone Propionate	Fluticasone Propionate	31	suppressed
Glipizide	Glipizide	30	suppressed
Testosterone Cypionate	Testosterone Cypionate	30	suppressed
Humalog Kwikpen U-100	Insulin Lispro	29	suppressed
Nitroglycerin	Nitroglycerin	29	16
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Donepezil Hcl	Donepezil Hcl	28	suppressed
Montelukast Sodium	Montelukast Sodium	28	11
Repatha Sureclick	Evolocumab	28	suppressed
Torsemide	Torsemide	28	suppressed
Primidone	Primidone	27	suppressed
Bupropion Hcl Sr	Bupropion Hcl	26	suppressed
Synthroid	Levothyroxine Sodium	26	suppressed
Benazepril Hcl	Benazepril Hcl	25	suppressed
Myrbetriq	Mirabegron	25	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	25	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Trulicity	Dulaglutide	25	suppressed
Baclofen	Baclofen	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	11
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Methylprednisolone	Methylprednisolone	24	23
Olmesartan Medoxomil	Olmesartan Medoxomil	24	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	24	suppressed
Cholestyramine	Cholestyramine (With Sugar)	23	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Tresiba Flextouch U-200	Insulin Degludec	23	suppressed
Cephalexin	Cephalexin	22	20
Meloxicam	Meloxicam	22	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	22	suppressed
Testosterone	Testosterone	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	13
Terazosin Hcl	Terazosin Hcl	20	suppressed
Topiramate	Topiramate	20	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Valsartan	Valsartan	18	suppressed
Bumetanide	Bumetanide	17	suppressed
Lorazepam	Lorazepam	17	16
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	17	suppressed
Bydureon Bcise	Exenatide Microspheres	16	suppressed
Flecainide Acetate	Flecainide Acetate	16	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	16	suppressed
Buprenorphine	Buprenorphine	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Labetalol Hcl	Labetalol Hcl	15	suppressed
Latanoprost	Latanoprost	15	suppressed
Levemir Flexpen	Insulin Detemir	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Azithromycin	Azithromycin	14	14
Cholestyramine Light	Cholestyramine	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	12
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	13	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Methadone Hcl	Methadone Hcl	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Praluent Pen	Alirocumab	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	11
Hydrocortisone	Hydrocortisone	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Nystatin	Nystatin	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error